Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*.

van Tilburg CM, Sanders EA, Nibbelke EE, Pieters R, Revesz T, Westers P, Wolfs TF, Bierings MB.

Br J Haematol. 2011 Feb;152(4):433-40. doi: 10.1111/j.1365-2141.2010.08463.x. Epub 2011 Jan 11.

PMID:
21223250
2.

Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.

Graubner UB, Porzig S, Jorch N, Kolb R, Wessalowski R, Escherich G, Janka GE.

Pediatr Blood Cancer. 2008 Feb;50(2):259-63.

PMID:
17635005
3.

Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.

Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, van Wering ER, Lo Nigro L, van der Does A, Locatelli F, Basso G, Aricò M.

J Clin Oncol. 2005 Oct 1;23(28):7161-7.

PMID:
16192600
6.

Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?

Te Poele EM, de Bont ES, Marike Boezen H, Revesz T, Bökkerink JP, Beishuizen A, Nijhuis IJ, Oude Nijhuis CS, Veerman AJ, Kamps WA.

Eur J Cancer. 2007 Nov;43(17):2532-6. Epub 2007 Aug 15.

PMID:
17702568
7.

Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.

Ortega JJ, Ribera JM, Oriol A, Bastida P, González ME, Calvo C, Egurbide I, Hernández Rivas JM, Rivas C, Alcalá A, Besalduch J, Maciá J, Gardella S, Carnero M, Lite JM, Casanova F, Martinez M, Fontanillas M, Feliu E, San Miguel JF; PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas.

Haematologica. 2001 Jun;86(6):586-95.

8.

Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).

Kamps WA, Bökkerink JP, Hählen K, Hermans J, Riehm H, Gadner H, Schrappe M, Slater R, van den Berg-de Ruiter E, Smets LA, de Vaan GA, Weening RS, van Weerden JF, van Wering ER, den der Does-van den Berg A.

Blood. 1999 Aug 15;94(4):1226-36.

9.

Childhood acute lymphoblastic leukemia: results of the Austrian Cooperative Study Group with the ALL A 84 protocol.

Gruemayer ER, Gadner H, Mutz I, Urban C, Ausserer B, Grienberger H, Juergenssen O, Koeller U, Mueller G, Panzer S, et al.

Med Pediatr Oncol. 1990;18(1):6-14.

PMID:
2403631
10.

Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.

Ribera JM, Ortega JJ, Oriol A, Fontanillas M, Hernández-Rivas JM, Brunet S, García-Conde J, Maldonado J, Zuazu J, Gardella S, Besalduch J, León P, Macià J, Domingo-Albós A, Feliu E, San Miguel JF.

Haematologica. 1998 Mar;83(3):222-30.

11.

[Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia].

Agger KE, Schrøder H, Rosthøj S, Carlsen NT, Schmiegelow K.

Ugeskr Laeger. 2002 Jan 21;164(4):488-92. Danish.

PMID:
11838420
12.

Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases.

van Tilburg CM, Bierings MB, Berbers GA, Wolfs TF, Pieters R, Bloem AC, Sanders EA.

Pediatr Blood Cancer. 2012 May;58(5):701-7. doi: 10.1002/pbc.23258. Epub 2011 Jul 25.

PMID:
21793184
13.

Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.

Paolucci G, Vecchi V, Favre C, Miniero R, Madon E, Pession A, Rondelli R, De Rossi G, Lo Nigro L, Porta F, Santoro N, Indolfi P, Basso G, Conter V, Aricò M; Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Haematologica. 2001 May;86(5):478-84.

14.

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.

Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T, Relling MV, Ribeiro RC, Crist WM, Evans WE.

N Engl J Med. 1997 Jun 19;336(25):1781-7.

15.

Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children.

Saarinen-Pihkala UM, Lanning M, Perkkiö M, Mäkipernaa A, Salmi TT, Hovi L, Vettenranta K.

Med Pediatr Oncol. 2000 May;34(5):319-27.

PMID:
10797353
16.
17.

The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

Escherich G, Tröger A, Göbel U, Graubner U, Pekrun A, Jorch N, Kaspers G, Zimmermann M, zur Stadt U, Kazemier K, Pieters R, Den Boer ML, Horstmann M, Janka GE; CoALL study group, Hamburg, Germany.

Haematologica. 2011 Jun;96(6):854-62. doi: 10.3324/haematol.2010.039735. Epub 2011 Feb 17.

18.

[Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].

Müller J, Kovács G, Jakab Z, Rényi I, Galántai I, Békési A, Kiss C, Nagy K, Kajtár P, Bartyik K, Masát P, Magyarosy E.

Orv Hetil. 2005 Jan 9;146(2):75-80. Hungarian.

PMID:
15724956
19.

Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma--a rationale for tailored supportive care.

Lex C, Körholz D, Kohlmüller B, Bönig H, Willers R, Kramm CM, Göbel U.

Support Care Cancer. 2001 Oct;9(7):514-21.

PMID:
11680831
20.

A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups.

Scrideli CA, Assumpção JG, Ganazza MA, Araújo M, Toledo SR, Lee ML, Delbuono E, Petrilli AS, Queiróz RP, Biondi A, Viana MB, Yunes JA, Brandalise SR, Tone LG.

Haematologica. 2009 Jun;94(6):781-9. doi: 10.3324/haematol.2008.003137.

Supplemental Content

Support Center